HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single versus repetitive injection of lignocaine in the management of carpal tunnel syndrome--a randomized controlled trial.

Abstract
The aim of this study was to determine the efficacy of single versus repetitive injection of lignocaine into the carpal tunnel for the management of carpal tunnel syndrome. The 42 patients included were randomly assigned to two Groups: group 1 was injected with 4 mL of 1% lignocaine once and Group 2 was injected with 4 mL of 1% lignocaine twice a week for 2 weeks. Clinical and electrophysiological evaluations were performed at the study onset, and at 6 and 12 weeks following the final injection. Initially, the groups were similar with respect to clinical and electrophysiological findings. All parameters in Group 2 improved 6 weeks post treatment (p < 0.05), and these improvements persisted at 12 weeks post treatment (p < 0.05). Repetitive local lignocaine injection was effective in reducing the symptoms of carpal tunnel syndrome and improving electrophysiological findings.
AuthorsS Akarsu, Ö Karadaş, F Tok, H Levent Gül, E Eroğlu
JournalThe Journal of hand surgery, European volume (J Hand Surg Eur Vol) Vol. 40 Issue 2 Pg. 179-83 (Feb 2015) ISSN: 2043-6289 [Electronic] England
PMID25061062 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Copyright© The Author(s) 2013.
Chemical References
  • Voltage-Gated Sodium Channel Blockers
  • Lidocaine
Topics
  • Adult
  • Carpal Tunnel Syndrome (drug therapy)
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Injections
  • Lidocaine (administration & dosage)
  • Middle Aged
  • Voltage-Gated Sodium Channel Blockers (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: